PROM1 and cancer: In this study, we determined that the percentage of CD133+CXCR4+ cancer cells in metastatic liver tumors was nearly eight times higher than that in primary colorectal tumors, indicating enrichment of this CSC subpopulation in metastatic liver tumors and their potential involvement in CRC metastasis to the liver.